HBK Sorce Advisory’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$964K Buy
11,015
+394
+4% +$35.1K 0.02% 250
2025
Q4
$1M Sell
10,621
-235
-2% -$18.4K 0.02% 238
2025
Q3
$843K Buy
10,856
+78
+0.7% +$6.65K 0.02% 254
2025
Q2
$980K Sell
10,778
-353
-3% -$32.2K 0.03% 229
2025
Q1
$1.04M Buy
11,131
+2
+0% +$179 0.03% 210
2024
Q4
$1.01M Buy
11,129
+1,017
+10% +$97K 0.03% 210
2024
Q3
$1.05M Sell
10,112
-348
-3% -$35.5K 0.03% 214
2024
Q2
$1.02M Sell
10,460
-60
-0.6% -$5.54K 0.04% 210
2024
Q1
$947K Sell
10,520
-250
-2% -$21.2K 0.03% 220
2023
Q4
$858K Sell
10,770
-640
-6% -$48.1K 0.03% 225
2023
Q3
$811K Sell
11,410
-138
-1% -$10.3K 0.04% 226
2023
Q2
$890K Sell
11,548
-1,111
-9% -$86K 0.04% 219
2023
Q1
$951K Sell
12,659
-20,981
-62% -$1.56M 0.04% 209
2022
Q4
$2.65M Buy
33,640
+21,212
+171% +$1.59M 0.07% 158
2022
Q3
$873K Buy
12,428
+4,002
+47% +$314K 0.06% 182
2022
Q2
$675K Sell
8,426
-3,208
-28% -$251K 0.05% 204
2022
Q1
$882K Sell
11,634
-542
-4% -$42.9K 0.05% 213
2021
Q4
$1.04M Sell
12,176
-327
-3% -$25.5K 0.05% 210
2021
Q3
$945K Buy
12,503
+299
+2% +$23.7K 0.05% 213
2021
Q2
$993K Sell
12,204
-341
-3% -$27.9K 0.05% 201
2021
Q1
$989K Sell
12,545
-1,668
-12% -$131K 0.06% 189
2020
Q4
$1.22M Buy
14,213
+1,121
+9% +$92.7K 0.08% 172
2020
Q3
$1.01M Buy
13,092
+152
+1% +$11.6K 0.07% 173
2020
Q2
$948K Buy
12,940
+1,059
+9% +$75.2K 0.07% 177
2020
Q1
$788K Buy
11,881
+117
+1% +$8.25K 0.08% 159
2019
Q4
$810K Buy
11,764
+156
+1% +$10.6K 0.07% 196
2019
Q3
$853K Sell
11,608
-157
-1% -$11.4K 0.08% 177
2019
Q2
$843K Buy
11,765
+289
+3% +$20.5K 0.08% 173
2019
Q1
$787K Buy
11,476
+860
+8% +$55.5K 0.08% 185
2018
Q4
$632K Sell
10,616
-2,237
-17% -$140K 0.07% 195
2018
Q3
$860K Buy
12,853
+110
+0.9% +$7.33K 0.1% 150
2018
Q2
$826K Buy
12,743
+326
+3% +$21.3K 0.1% 152
2018
Q1
$890K Buy
12,417
+446
+4% +$32.1K 0.11% 139
2017
Q4
$903K Buy
11,971
+3,248
+37% +$237K 0.11% 142
2017
Q3
$635K Sell
8,723
-638
-7% -$46K 0.1% 150
2017
Q2
$694K Buy
+9,361
New +$695K 0.11% 137
2017
Q1
Sell
-8,014
Closed -$561K 324
2016
Q4
$524K Sell
8,014
-45
-0.6% -$3.08K 0.09% 156
2016
Q3
$598K Buy
8,059
+141
+2% +$10.4K 0.12% 133
2016
Q2
$580K Buy
7,918
+435
+6% +$31K 0.12% 129
2016
Q1
$529K Buy
7,483
+4,323
+137% +$288K 0.12% 122
2015
Q4
$211K Buy
+3,160
New +$210K 0.06% 193
2013
Q4
Sell
-3,782
Closed -$224K 183
2013
Q3
$224K Sell
3,782
-3,434
-48% -$203K 0.09% 152
2013
Q2
$414K Buy
+7,216
New +$428K 0.09% 157

Other funds holding CL

HBK Sorce Advisory's CL Position: Q1 2026 in Review

HBK Sorce Advisory increased its Colgate-Palmolive (CL) stake by 3.7% in Q1 2026, buying an estimated $35.1K and bringing the position to 11,015 shares worth $964K. The position accounts for 0.02% of the portfolio, ranked #250.

HBK Sorce Advisory first reported a position in CL in Q2 2013 and has held it in 43 quarters since. The position peaked at $2.65M in Q4 2022. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • HBK Sorce Advisory held 11,015 shares of Colgate-Palmolive worth $964K as of Q1 2026.
  • HBK Sorce Advisory bought 394 Colgate-Palmolive shares in Q1 2026, an estimated $35.1K.
  • Colgate-Palmolive made up 0.02% of HBK Sorce Advisory's portfolio in Q1 2026, its #250 holding.
  • HBK Sorce Advisory first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 43 quarters since.
  • HBK Sorce Advisory's Colgate-Palmolive position peaked at $2.65M in Q4 2022.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on HBK Sorce Advisory's 13F filing for Q1 2026, filed 11 May 2026.